Citadel Advisors’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.8M | Sell |
320,143
-361,790
| -53% | -$6.55M | ﹤0.01% | 1780 |
|
|
2025
Q1 | $14M | Sell |
681,933
-293,898
| -30% | -$6.02M | ﹤0.01% | 1067 |
|
|
2024
Q4 | $25.1M | Buy |
975,831
+453,366
| +87% | +$11.7M | ﹤0.01% | 824 |
|
|
2024
Q3 | $8.67M | Buy |
522,465
+308,311
| +144% | +$5.12M | ﹤0.01% | 1367 |
|
|
2024
Q2 | $4.11M | Sell |
214,154
-240,180
| -53% | -$4.61M | ﹤0.01% | 1831 |
|
|
2024
Q1 | $10.7M | Buy |
454,334
+433,288
| +2,059% | +$10.2M | ﹤0.01% | 1250 |
|
|
2023
Q4 | $235K | Sell |
21,046
-10,351
| -33% | -$116K | ﹤0.01% | 4450 |
|
|
2023
Q3 | $290K | Buy |
+31,397
| New | +$290K | ﹤0.01% | 4280 |
|